Neonatal mouse-derived engineered cardiac tissue: A novel model system for studying genetic heart disease

Circulation Research

Volumn 109, Issue 1, 2011, Pages 8-16

  De Lange, W J ^a   Hegge, L F ^a   Grimes, A C ^a   Tong, C W ^b   Brost, T M ^a   Moss, R L ^b   Ralphe, J C ^a  

^a H6/516G CSC ^*  (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

cardiomyopathy hypertrophic; engineered cardiac tissue; myosin binding protein C

Indexed keywords

MYOSIN BINDING PROTEIN C;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; GENE MUTATION; GENETIC DISORDER; HEART; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HYPERTROPHIC CARDIOMYOPATHY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TISSUE ENGINEERING; WILD TYPE;

ADENOVIRIDAE; ANIMALS; ANIMALS, NEWBORN; CARDIOMYOPATHY, HYPERTROPHIC; CARRIER PROTEINS; HUMANS; MICE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; TISSUE ENGINEERING;

EID: 79960001856     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.111.242354     Document Type: Article

References (45)

1. Eschenhagen T, Fink C, Remmers U, Scholz H, Wattchow J, Weil J, Zimmermann W, Dohmen HH, Schafer H, Bishopric N, Wakatsuki T, Elson EL. Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB J. 1997;11: 683-694. (Pubitemid 27318285)
2. Zimmermann WH, Fink C, Kralisch D, Remmers U, Weil J, Eschenhagen T. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol Bioeng. 2000;68:106-114. (Pubitemid 30163499)
3. Tobita K, Liu LJ, Janczewski AM, Tinney JP, Nonemaker JM, Augustine S, Stolz DB, Shroff SG, Keller BB. Engineered early embryonic cardiac tissue retains proliferative and contractile properties of developing embryonic myocardium. Am J Physiol Heart Circ Physiol. 2006;291: H1829-H1837. (Pubitemid 44497690)
4. Clause KC, Tinney JP, Liu LJ, Gharaibeh B, Huard J, Kirk JA, Shroff SG, Fujimoto KL, Wagner WR, Ralphe JC, Keller BB, Tobita K. A threedimensional gel bioreactor for assessment of cardiomyocyte induction in skeletal muscle-derived stem cells. Tissue Eng Part C Methods. 2010;16: 375-385.
5. Hansen A, Eder A, Bonstrup M, Flato M, Mewe M, Schaaf S, Aksehirlioglu B, Schworer A, Uebeler J, Eschenhagen T. Development of a drug screening platform based on engineered heart tissue. Circ Res. 2010;107:35-44.
6. Xi J, Khalil M, Shishechian N, Hannes T, Pfannkuche K, Liang H, Fatima A, Haustein M, Suhr F, Bloch W, Reppel M, Saric T, Wernig M, Janisch R, Brockmeier K, Hescheler J, Pillekamp F. Comparison of contractile behavior of native murine ventricular tissue and cardiomyocytes derived from embryonic or induced pluripotent stem cells. FASEB J. 2010;24: 2739-2751.
7. Carrier RL, Papadaki M, Rupnick M, Schoen FJ, Bursac N, Langer R, Freed LE, Vunjak-Novakovic G. Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. Biotechnol Bioeng. 1999;64:580-589. (Pubitemid 29359808)
8. Engelmayr GC Jr, Cheng M, Bettinger CJ, Borenstein JT, Langer R, Freed LE. Accordion-like honeycombs for tissue engineering of cardiac anisotropy. Nat Mater. 2008;7:1003-1010.
9. Radisic M, Park H, Shing H, Consi T, Schoen FJ, Langer R, Freed LE, Vunjak-Novakovic G. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci USA. 2004;101:18129-18134. (Pubitemid 40054085)
10. Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, Netoff TI, Taylor DA. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med. 2008;14:213-221. (Pubitemid 351214548)
11. Shimizu T, Yamato M, Isoi Y, Akutsu T, Setomaru T, Abe K, Kikuchi A, Umezu M, Okano T. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperatureresponsive cell culture surfaces. Circ Res. 2002;90:e40.
12. Sekine H, Shimizu T, Yang J, Kobayashi E, Okano T. Pulsatile myocardial tubes fabricated with cell sheet engineering. Circulation. 2006; 114:I87-I93. (Pubitemid 44297134)
13. Bel A, Planat-Bernard V, Saito A, Bonnevie L, Bellamy V, Sabbah L, Bellabas L, Brinon B, Vanneaux V, Pradeau P, Peyrard S, Larghero J, Pouly J, Binder P, Garcia S, Shimizu T, Sawa Y, Okano T, Bruneval P, Desnos M, Hagege AA, Casteilla L, Puceat M, Menasche P. Composite cell sheets: a further step toward safe and effective myocardial regeneration by cardiac progenitors derived from embryonic stem cells. Circulation. 2010;122:S118-S123.
14. Naito H, Melnychenko I, Didie M, Schneiderbanger K, Schubert P, Rosenkranz S, Eschenhagen T, Zimmermann WH. Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Circulation. 2006;114:I72-I78. (Pubitemid 44297132)
15. Huang YC, Khait L, Birla RK. Contractile three-dimensional bioengineered heart muscle for myocardial regeneration. J Biomed Mater Res A. 2007;80:719-731. (Pubitemid 46239085)
16. Bian W, Liau B, Badie N, Bursac N. Mesoscopic hydrogel molding to control the 3D geometry of bioartificial muscle tissues. Nat Protoc. 2009;4:1522-1534.
17. Marston S, Copeland O, Jacques A, Livesey K, Tsang V, McKenna WJ, Jalilzadeh S, Carballo S, Redwood C, Watkins H. Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency. Circ Res. 2009;105:219-222.
18. Wang L, Seidman JG, Seidman CE. Narrative review: harnessing molecular genetics for the diagnosis and management of hypertrophic cardiomyopathy. Ann Intern Med. 2010;152:513-520, W181.
19. Kaski JP, Syrris P, Esteban MT, Jenkins S, Pantazis A, Deanfield JE, McKenna WJ, Elliott PM. Prevalence of sarcomere protein gene mutations in preadolescent children with hypertrophic cardiomyopathy. Circ Cardiovasc Genet. 2009;2:436-441.
20. Harris SP, Bartley CR, Hacker TA, McDonald KS, Douglas PS, Greaser ML, Powers PA, Moss RL. Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice. Circ Res. 2002;90:594-601. (Pubitemid 34640910)
21. Korte FS, McDonald KS, Harris SP, Moss RL. Loaded shortening, power output, and rate of force redevelopment are increased with knockout of cardiac myosin binding protein-C. Circ Res. 2003;93:752-758. (Pubitemid 37288670)
22. Stelzer JE, Dunning SB, Moss RL. Ablation of cardiac myosin-binding protein-C accelerates stretch activation in murine skinned myocardium. Circ Res. 2006;98:1212-1218. (Pubitemid 43948108)
23. Stelzer JE, Fitzsimons DP, Moss RL. Ablation of myosin-binding protein-C accelerates force development in mouse myocardium. Biophys J. 2006;90:4119-4127. (Pubitemid 43846126)
24. Stelzer JE, Patel JR, Moss RL. Protein kinase A-mediated acceleration of the stretch activation response in murine skinned myocardium is eliminated by ablation of CMYBP-C. Circ Res. 2006;99:884-890. (Pubitemid 44556388)
25. Stelzer JE, Patel JR, Walker JW, Moss RL. Differential roles of cardiac myosin-binding protein C and cardiac troponin I in the myofibrillar force responses to protein kinase A phosphorylation. Circ Res. 2007;101:503-511. (Pubitemid 47347881)
26. Tong CW, Stelzer JE, Greaser ML, Powers PA, Moss RL. Acceleration of crossbridge kinetics by protein kinase A phosphorylation of cardiac myosin binding protein C modulates cardiac function. Circ Res. 2008;103:974-982.
27. Atkins DL, Marvin WJ Jr. Chronotropic responsiveness of developing sinoatrial and ventricular rat myocytes to autonomic agonists following adrenergic and cholinergic innervation in vitro. Circ Res. 1989;64: 1051-1062. (Pubitemid 19155775)
28. Lloyd TR, Marvin WJ Jr. Sympathetic innervation improves the contractile performance of neonatal cardiac ventricular myocytes in culture. J Mol Cell Cardiol. 1990;22:333-342. (Pubitemid 20155888)
29. Asnes CF, Marquez JP, Elson EL, Wakatsuki T. Reconstitution of the Frank-Starling mechanism in engineered heart tissues. Biophys J. 2006; 91:1800-1810. (Pubitemid 44352444)
30. Chlopcikova S, Psotova J, Miketova P. Neonatal rat cardiomyocytes: a model for the study of morphological, biochemical and electrophysiological characteristics of the heart. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2001;145:49-55.
31. Eschenhagen T, Didie M, Heubach J, Ravens U, Zimmermann WH. Cardiac tissue engineering. Transpl Immunol. 2002;9:315-321.
32. Kim do E, Lee EJ, Martens TP, Kara R, Chaudhry HW, Itescu S, Costa KD. Engineered cardiac tissues for in vitro assessment of contractile function and repair mechanisms. Conf Proc IEEE Eng Med Biol Soc. 2006;1:849-852. (Pubitemid 46519996)
33. De Lange WJ, Tong CW, Ralphe JC. Electrical pacing of rat engineered cardiac tissue (ECT) improves cardiac function by increasing cardiomyocyte differentiation and survival. Pediatr Res. 2009;66:470.
34. de Tombe PP, ter Keurs HE. Force and velocity of sarcomere shortening in trabeculae from rat heart: effects of temperature. Circ Res. 1990;66: 1239-1254. (Pubitemid 20147741)
35. Janssen PM. Kinetics of cardiac muscle contraction and relaxation are linked and determined by properties of the cardiac sarcomere. Am J Physiol Heart Circ Physiol. 2010;299:H1092-H1099.
36. Janssen PM, Stull LB, Marban E. Myofilament properties comprise the rate-limiting step for cardiac relaxation at body temperature in the rat. Am J Physiol Heart Circ Physiol. 2002;282:H499-H507. (Pubitemid 34654973)
37. Kushnir A, Shan J, Betzenhauser MJ, Reiken S, Marks AR. Role of CaMKIIdelta phosphorylation of the cardiac ryanodine receptor in the force frequency relationship and heart failure. Proc Natl Acad Sci USA. 2010;107:10274-10279.
38. Pillekamp F, Halbach M, Reppel M, Rubenchyk O, Pfannkuche K, Xi JY, Bloch W, Sreeram N, Brockmeier K, Hescheler J. Neonatal murine heart slices: a robust model to study ventricular isometric contractions. Cell Physiol Biochem. 2007;20:837-846. (Pubitemid 350059726)
39. Tong CW, Gaffin RD, Zawieja DC, Muthuchamy M. Roles of phosphorylation of myosin binding protein-C and troponin I in mouse cardiac muscle twitch dynamics. J Physiol. 2004;558:927-941. (Pubitemid 39199113)
40. Tanaka H, Shigenobu K. Effect of ryanodine on neonatal and adult rat heart: developmental increase in sarcoplasmic reticulum function. J Mol Cell Cardiol. 1989;21:1305-1313. (Pubitemid 20046105)
41. Radisic M, Malda J, Epping E, Geng W, Langer R, Vunjak-Novakovic G. Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Biotechnol Bioeng. 2006;93:332-343.
42. Chiu LL, Radisic M, Vunjak-Novakovic G. Bioactive scaffolds for engineering vascularized cardiac tissues. Macromol Biosci. 2010;10: 1286-1301.
43. Chiu LL, Radisic M. Scaffolds with covalently immobilized VEGF and angiopoietin-1 for vascularization of engineered tissues. Biomaterials. 2010;31:226-241.
44. Radisic M, Marsano A, Maidhof R, Wang Y, Vunjak-Novakovic G. Cardiac tissue engineering using perfusion bioreactor systems. Nat Protoc. 2008;3: 719-738. (Pubitemid 351516766)
45. Brickson S, Fitzsimons DP, Pereira L, Hacker T, Valdivia H, Moss RL. In vivo left ventricular functional capacity is compromised in CMYBP-C null mice. Am J Physiol Heart Circ Physiol. 2007;292:H1747-H1754. (Pubitemid 46572397)